Información:
Error:
ID
30477
Descripción
A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD); ODM derived from: https://clinicaltrials.gov/show/NCT00463242
Link
https://clinicaltrials.gov/show/NCT00463242
Palabras clave
Versiones (1)
- 7/6/18 7/6/18 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
7 de junio de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Major Depressive Disorder NCT00463242
Eligibility Major Depressive Disorder NCT00463242
- StudyEvent: Eligibility
Similar models
Eligibility Major Depressive Disorder NCT00463242
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Age
Item
male and female adults, 18 through 70 years of age, inclusive
boolean
C0001779 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosis of major depressive disorder according to dsm-iv criteria
boolean
C1269683 (UMLS CUI [1])
Hamilton Depression Rating Scale 17 Item Clinical Classification
Item
ham-d17 total score > or = 22 at screening and baseline
boolean
C3639712 (UMLS CUI [1])
Paroxetine | Disease Response Absent
Item
history of non-response to paroxetine
boolean
C0070122 (UMLS CUI [1])
C1704632 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1704632 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Agomelatine
Item
patients who have been previously treated with agomelatine
boolean
C0971637 (UMLS CUI [1])
Bipolar I disorder | Bipolar II disorder | Schizophrenia | Schizoaffective Disorder | Eating Disorders | Obsessive-Compulsive Disorder
Item
history of bipolar disorder (i or ii), schizophrenia, schizoaffective disorder, eating disorder, or obsessive compulsive disorder
boolean
C0853193 (UMLS CUI [1])
C0236788 (UMLS CUI [2])
C0036341 (UMLS CUI [3])
C0036337 (UMLS CUI [4])
C0013473 (UMLS CUI [5])
C0028768 (UMLS CUI [6])
C0236788 (UMLS CUI [2])
C0036341 (UMLS CUI [3])
C0036337 (UMLS CUI [4])
C0013473 (UMLS CUI [5])
C0028768 (UMLS CUI [6])
Axis I diagnosis | Exception Major Depressive Disorder
Item
any current axis i disorder other than major depressive disorder which is the focus of treatment
boolean
C0270287 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1269683 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C1269683 (UMLS CUI [2,2])
Substance Use Disorders | Substance Dependence
Item
substance or alcohol abuse in the last 30 days, dependence in the last 6 months
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
C0038580 (UMLS CUI [2])
Psychotropic Drugs
Item
use of any psychoactive medication after the screening visit
boolean
C0033978 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Absent
Item
female patients of childbearing potential who are not using effective contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])